societ
chang
character
increas
global
traffic
breakdown
histor
barrier
transit
fundament
alter
natur
histori
viral
infect
allow
sporad
spread
infecti
agent
around
world
within
day
outbreak
exemplifi
sever
acut
respiratori
syndrom
viru
sar
highli
pathogen
avian
influenza
virus
eg
subtyp
strain
middl
eastern
respiratori
syndrom
coronaviru
merscov
result
high
morbid
mortal
caus
signific
disrupt
societi
due
public
fear
infect
necessari
government
respons
enserink
van
den
brand
et
al
interestingli
viral
infect
result
patholog
mani
virus
adapt
well
enough
human
undergo
robust
replic
cycl
littl
evid
immun
recognit
respons
least
immun
respons
damag
host
exampl
sendai
viru
close
rel
human
respiratori
pathogen
parainfluenza
infect
human
analog
manner
relat
respiratori
virus
caus
diseas
desmecht
interplay
viru
host
factor
dictat
patholog
variou
infect
scenario
poorli
understood
influenza
virus
iav
repres
interest
relev
model
studi
phenomenon
iav
zoonos
emerg
period
anim
reservoir
sometim
establish
endem
human
webster
et
al
initi
incurs
spread
worldwid
term
pandem
often
character
sever
morbid
high
mortal
exemplifi
pandem
kill
million
person
howev
sever
decad
circul
strain
adapt
gener
becom
less
pathogen
chang
viru
result
reduc
morbid
correspond
host
pathway
process
involv
explic
although
sever
mechan
like
respons
tendenc
season
influenza
strain
gain
excess
glycosyl
surfac
protein
hemagglutinin
ha
identifi
key
factor
el
moussi
et
al
kim
park
medina
et
al
sun
et
al
vigerust
et
al
zhang
et
al
mechanist
gain
glycosyl
site
ha
globular
head
link
increas
collagen
lectin
collectin
bind
result
viru
neutral
tate
et
al
vigerust
et
al
physic
alter
hareceptorbind
site
therebi
affect
receptor
bind
specif
avid
potenti
alter
viru
tropism
jayaraman
et
al
wang
et
al
also
studi
howev
observ
differenti
inflammatori
potenti
base
glycosyl
differ
downstream
effect
pathogenesi
explor
ha
protein
homotrim
ectodomain
compos
globular
head
stalk
region
wilson
et
al
mediat
attach
viral
particl
host
cell
escap
endosom
luo
newli
produc
ha
sort
protein
secretori
pathway
transloc
er
transport
plasma
membran
ha
undergo
posttransl
modif
er
golgi
apparatu
glycan
ad
specif
site
nlink
glycosyl
glycan
primarili
stalk
region
need
proper
protein
fold
transport
daniel
et
al
robert
et
al
other
globular
head
known
function
propos
role
facilit
immun
escap
antibodi
job
et
al
tate
et
al
gener
glycosyl
import
role
protein
fold
qualiti
control
er
integr
protein
qualiti
control
mechan
cellular
respons
accumul
nonn
misfold
protein
er
stress
unfold
protein
respons
upr
potenti
elimin
roth
et
al
alter
andor
disturb
protein
glycosyl
connect
human
diseas
gregersen
et
al
roth
et
al
previou
studi
link
ha
glycosyl
iav
pathogen
want
explor
interplay
ha
protein
host
pathway
better
understand
fundament
relationship
viru
recognit
induct
immun
respons
subsequ
patholog
find
reveal
mechan
selfnonselfdiscrimin
poorli
glycosyl
viru
protein
pandem
iav
strain
recogn
nonself
mediat
viru
recognit
airway
inflammatori
respons
pathogen
virus
adapt
human
select
excess
glycosyl
site
virus
artifici
construct
carri
excess
glycan
recogn
innat
sens
mechan
abl
replic
without
patholog
consequ
understand
differ
pathobiolog
pandem
season
iav
investig
immun
respons
patholog
use
relev
natur
occur
strain
infect
mice
recent
pandem
iav
result
muchstrong
lung
immun
respons
weight
loss
infect
recent
season
iav
figur
ha
protein
pandem
iav
character
poor
glycosyl
globular
head
known
pandem
strain
previou
introduct
pandem
iav
includ
strain
human
iav
virus
subsequ
acquir
addit
glycosyl
site
ha
globular
head
adapt
human
vigerust
et
al
understand
impact
glycosyl
chang
iav
pathogen
adapt
human
util
virus
carri
either
pandem
hk
poorli
glycosyl
season
pan
heavili
glycosyl
hana
protein
variou
combin
iav
creat
eightplasmid
revers
genet
system
carri
six
intern
gene
segment
iav
laboratori
strain
appropri
gene
segment
express
pandem
hk
season
pan
surfac
protein
inflammatori
respons
patholog
could
clearli
link
pandem
ha
express
figur
avoid
potenti
confound
caus
differ
viru
accumul
differ
virus
figur
next
test
whether
could
season
pandem
iav
addit
correspond
glycosyl
site
isogen
virus
repres
pandem
iav
wt
two
virus
carri
two
ii
four
iv
addit
glycosyl
site
globular
head
ha
construct
describ
vigerust
et
al
stepwis
addit
glycan
ha
absenc
chang
result
correspondingli
reduc
airway
inflamm
patholog
upon
infect
differ
iav
figur
analys
demonstr
reduc
morbid
level
bodi
weight
loss
figur
mortal
figur
associ
increas
glycosyl
infect
second
mous
line
reveal
compar
result
figur
broaden
phenotyp
final
addit
least
two
addit
glycan
pandem
ha
protein
associ
reduc
viral
growth
figur
exclud
viru
propag
disadvantag
primari
mechan
reduc
pathogen
experi
addit
two
glycan
iv
viru
result
attenu
growth
figur
like
due
collectin
neutral
read
et
al
vigerust
et
al
led
us
exclud
viru
later
molecular
mechanist
studi
confound
result
initi
find
increas
proinflammatori
cytokin
express
lung
infect
virus
express
pandem
iav
assess
impact
ha
glycosyl
airway
inflamm
investig
respons
isogen
iav
differ
amount
glycosyl
site
ha
demonstr
dampen
inflamm
stepwis
addit
glycan
assess
proinflammatori
cytokinechemokin
express
mrna
level
figur
well
protein
level
figur
reveal
strong
inflammatori
respons
upon
wt
viru
infect
stepwis
reduc
inflamm
upon
infect
ii
iv
viru
variant
infect
wt
viru
also
result
infiltr
immun
cell
airway
compar
lower
cell
count
upon
ii
iv
viru
infect
figur
analysi
specif
cell
type
demonstr
deplet
resid
airway
macrophag
shown
earlier
group
ghoneim
et
al
accumul
inflammatori
cell
includ
exud
macrophag
neutrophil
strongest
upon
wt
infect
lesser
impact
ii
iv
viru
infect
figur
analysi
ratio
resid
macrophag
exud
macrophag
neutrophil
balf
show
almost
complet
shift
resid
macrophag
naiv
mice
infiltr
inflammatori
cell
wt
viru
infect
shift
seen
lesser
extent
ii
margin
extent
iv
viru
infect
figur
taken
togeth
data
clearli
demonstr
impact
ha
glycosyl
airway
inflamm
along
differ
detect
ha
glycosylationdepend
increas
lung
patholog
use
patholog
marker
total
balf
protein
figur
balf
ldh
level
figur
lung
edema
figur
histolog
analys
confirm
gross
differ
lung
patholog
upon
wt
ii
iv
viru
infect
figur
mark
denud
bronchiol
follow
wt
viru
infect
figur
final
analys
marker
lung
physiolog
reveal
advers
effect
lung
homeostasi
function
character
gener
increas
airway
resist
decreas
lung
complianc
upon
infect
wt
viru
find
reduc
upon
infect
higher
glycosyl
iav
virus
figur
consist
observ
decreas
inflammatori
respons
decreas
lung
injuri
although
find
diminish
pathogen
iv
viru
may
partial
due
differ
viral
titer
altern
mechan
must
respons
differ
wt
ii
virus
variant
differ
replic
viral
lung
load
order
understand
mechan
underli
associ
ha
glycosyl
inflamm
upon
iav
infect
assess
whole
lung
transcriptom
microarray
analysi
reveal
clear
differ
experiment
group
wtvirusinfect
lung
display
differ
gene
express
profil
principalcompon
analysi
pca
compar
lung
naiv
mice
ii
ivvirusinfect
mice
figur
express
profil
iivirusinfect
lung
closer
remain
distinct
wtvirusinfect
lung
wherea
gene
express
profil
ivinfect
lung
compar
distinct
naiv
mous
lung
figur
heatmap
analys
reveal
candid
group
gene
upregul
wtvirusinfect
lung
compar
naiv
mice
lesser
extent
upregul
ii
even
weaker
signal
ivvirusinfect
lung
figur
focus
group
gene
strongest
associ
glycosyl
demonstr
enrich
gene
involv
inflammatori
respons
figur
interest
gene
link
er
stress
upr
highli
correl
glycosyl
statu
prompt
investig
figur
probe
molecular
mechan
increas
inflamm
upon
pandem
iav
infect
next
assess
potenti
involv
er
stress
upr
isol
infect
process
lung
epitheli
cell
main
cell
type
product
infect
iav
focus
virus
compar
growth
characterist
wt
ii
viru
avoid
confound
profound
differ
inflammatori
respons
evid
upon
infect
figur
infect
wt
viru
result
higher
induct
mrna
compar
ii
viru
infect
result
affect
reduc
accumul
viral
materi
concern
could
confound
data
ii
viru
replic
compar
wt
viru
system
figur
show
gener
compar
slightli
better
growth
relev
cell
line
figur
expand
number
gene
investig
qpcrbase
analysi
reveal
strong
upregul
multipl
inflammatori
gene
wt
viru
compar
iivirusinfect
lung
epitheli
cell
figur
addit
experi
primari
normal
human
bronchial
epitheli
cell
nhbe
confirm
find
morepronounc
inflammatori
respons
upon
wt
viru
infect
second
relev
human
cell
model
figur
absenc
differ
replic
figur
next
assess
contribut
differ
er
stress
pathway
inflammatori
respons
upon
inflamm
involv
alter
immun
reaction
upon
infect
iav
set
differenti
glycosyl
ha
protein
analyz
phosphoryl
demonstr
activ
wtvirusinfect
cell
figur
lesser
activ
iivirusinfect
cell
consist
subsequ
induct
mitogenactiv
protein
map
kinas
jnk
pathway
figur
link
er
stress
darl
cook
involv
inflammatori
respons
iav
infect
ehrhardt
et
al
examin
activ
perk
addit
pathway
trigger
upon
er
stress
could
illustr
perk
phosphoryl
wt
compar
ii
infect
found
viru
moi
depend
figur
activ
cleavag
minim
argu
contribut
iavinduc
erstressmedi
inflamm
seem
minim
none
figur
analyz
express
sever
uprdepend
gene
reveal
weak
upregul
gene
upon
wt
infect
without
gener
pattern
induct
figur
point
time
strong
induct
inflammatori
respons
figur
data
exclud
specif
contribut
particular
upr
gene
suggest
activ
er
stress
kinas
perk
subsequ
initi
inflammatori
pathway
potenti
critic
event
probe
hypothesi
use
regulatori
compound
phenylbutyr
acid
pba
inhibit
er
stress
could
illustr
interplay
pathway
induct
inflammatori
respons
upon
infect
pandem
iav
figur
activ
map
kinas
jnk
pathway
stronger
upon
wt
viru
infect
compar
ii
viru
infect
inhibit
er
stress
result
reduct
wtvirusinduc
activ
pathway
along
diminish
activ
figur
cytokinechemokin
analys
inflammatori
respons
upon
pandem
iav
infect
support
interpret
decreas
induct
inflammatori
gene
inhibit
figur
data
confirm
second
molecular
chaperon
tudca
also
decreas
er
stress
figur
broaden
relev
explic
mechan
er
stress
induct
inflammatori
respons
relat
glycosyl
statu
util
differ
respiratori
syncyti
virus
rsv
propag
either
vero
cell
major
glycosyl
surfac
protein
rsv
truncat
propag
vero
cell
result
signific
loss
glycosyl
derscheid
et
al
kwila
et
al
rixon
et
al
analyz
inflammatori
respons
upon
infect
two
version
rsv
reveal
differ
express
proinflammatori
cytokin
differenti
induct
express
figur
along
compar
viru
growth
figur
show
glycosyl
statu
rsv
surfac
protein
also
affect
induct
cellular
immun
respons
clearli
establish
link
ha
glycosyl
er
stress
activ
inflammatori
respons
epitheli
cell
lung
next
sought
demonstr
overexuber
inflammatori
respons
basi
pandem
iav
pathogen
therefor
manipul
inflammatori
respons
use
sever
approach
analyz
outcom
iav
pathogenesi
first
artifici
stimul
inflammatori
respons
use
exogen
lipoteicho
acid
lta
iivirusinfect
lung
result
elev
pathogen
level
wt
viru
infect
figur
show
dampen
inflamm
upon
ii
viru
infect
basi
reduc
morbid
mortal
model
addit
reduct
inflammatori
respons
upon
wt
viru
infect
rescu
infect
anim
either
use
mice
figur
alter
inflammatori
respons
less
infiltr
inflammatori
cell
conradi
et
al
dess
et
al
frangogianni
et
al
van
zoelen
et
al
use
imatinib
figur
broadli
activ
antiinflammatori
drug
wolf
et
al
approach
help
wtinfect
anim
surviv
wherea
control
anim
die
figur
support
concept
er
stress
sourc
patholog
inflamm
treatment
mice
chemic
chaperon
decreas
er
stress
promot
protein
fold
rescu
wtinfect
anim
figur
confirm
key
find
second
recent
pandem
iav
viru
util
initi
comparison
season
strain
figur
construct
otherwis
isogen
ii
version
repeat
select
experi
reduc
immun
respons
upon
er
stress
inhibit
seen
comparison
untreat
wt
viru
treatment
pba
figur
addit
two
glycan
globular
head
ha
result
reduc
inflammatori
respons
line
reduc
er
stress
induct
level
mrna
express
figur
well
decreas
morbid
mortal
figur
taken
togeth
data
illumin
interplay
poorli
glycosyl
ha
protein
zoonot
introduc
human
pandem
outbreak
induct
inflamm
er
stress
pathway
result
patholog
specul
pandem
virus
adapt
human
host
select
variant
increas
glycosyl
avoid
erstressmedi
immun
recognit
result
massiv
airway
inflamm
patholog
benefit
viru
versatil
interplay
invad
pathogen
host
immun
respons
critic
determin
sever
outcom
infect
pathogenhost
coevolut
result
manifold
receptor
sens
pathogen
mulhern
et
al
although
recognit
viral
rna
sensor
rigi
thought
one
import
mechan
sens
iav
develop
countermeasur
system
complex
interact
suggest
pathway
must
oper
current
studi
address
crucial
involv
er
stress
pathway
upr
inflammatori
respons
pathogen
upon
viral
infect
includ
iav
rsv
innat
sens
occur
level
protein
process
recogn
nascent
ha
protein
pandem
strain
nonself
result
poor
surfac
glycosyl
almost
identifi
innat
sensor
virus
reli
recognit
differ
nucleic
acid
composit
trigger
immun
respons
interestingli
patholog
model
stem
immun
respons
direct
damag
viru
es
propos
pathway
oper
intracellular
innat
sensor
distinguish
self
nonself
recogn
differenti
glycosyl
protein
foreign
trigger
immun
respons
support
data
evid
regulatori
involv
er
stress
microbi
infect
recent
shown
muralidharan
mandrekar
interplay
er
stress
viral
infect
suggest
human
pathogen
hbv
liu
et
al
hcv
chan
influenza
viru
hassan
et
al
roberson
et
al
recent
potenti
direct
contribut
er
stress
recognit
viral
infect
specul
upon
smith
final
gener
contribut
er
stress
lung
inflamm
well
acut
lung
injuri
human
patient
recent
describ
kim
et
al
link
observ
provid
mechan
tie
differenti
glycosyl
rel
perhap
natur
protein
trigger
er
stress
activ
signal
event
downstream
upr
result
inflamm
patholog
natur
host
nich
iav
gut
wild
bird
waterfowl
previou
pandem
virus
left
environ
cross
speci
barrier
establish
endem
infect
respiratori
tract
human
poorli
glycosyl
virus
would
predict
recogn
mechan
promot
virul
morbid
inde
pandem
virus
includ
strain
typic
virul
relat
season
strain
reed
et
al
virul
pandem
strain
link
clearli
ha
glycosyl
statu
ad
support
import
mechan
sun
et
al
tumpey
et
al
decad
circul
neg
select
trait
allow
immun
recognit
would
favor
accumul
glycan
ha
surfac
avoid
trigger
er
stress
pattern
recapitul
natur
lineag
glycosyl
variant
pandem
strain
alreadi
detect
natur
suggest
adapt
avoid
sens
alreadi
take
place
mullick
et
al
emphas
need
evalu
consequ
iav
pathogen
differ
viru
isol
medina
et
al
zhang
et
al
broadli
like
abil
discrimin
nonself
level
protein
fold
process
util
maintain
cellular
homeostasi
face
viral
invas
provid
altern
nucleicacidbas
innat
sensor
circumv
varieti
strategi
howev
data
demonstr
may
also
untoward
consequ
patholog
result
unrestrain
inflamm
societ
climat
chang
drive
emerg
pathogen
new
human
anim
reservoir
deeper
understand
virushost
interact
molecular
level
need
prevent
mitig
diseas
madindarbi
canin
kidney
mdck
cell
cultur
mem
wherea
human
lung
epitheli
cell
line
human
embryon
kidney
cell
cultiv
dmem
nhbe
lonza
cultur
accord
manufactur
protocol
use
begm
bullet
kit
lonza
refreez
count
upon
initi
cell
expans
singl
vial
thaw
directli
seed
experi
cell
cultur
media
supplement
heatinactiv
fetal
bovin
serum
season
iav
isol
taken
strain
collect
st
jude
children
research
hospit
recombin
iav
creat
describ
earlier
vigerust
et
al
pandem
iav
isogen
mutant
viru
ha
ii
rescu
revers
genet
plasmid
system
kindli
provid
dr
thorsten
wolff
robert
koch
institut
two
addit
glycosyl
site
found
season
iav
introduc
pandem
ha
creat
ha
ii
viru
ha
ii
comparison
wt
note
revers
genet
plasmid
ha
protein
access
number
carri
mutat
differ
virus
consist
six
intern
gene
segment
apuerto
differ
combin
season
pan
pandem
ahong
hk
ha
na
segment
refer
virus
creat
describ
earlier
vigerust
et
al
isogen
virus
consist
intern
gene
ahong
hk
ha
na
segment
either
wildtyp
ha
hk
wt
carri
two
hk
ii
four
addit
hk
iv
glycosyl
site
vigerust
et
al
presenc
desir
mutat
viru
confirm
sequenc
virus
grown
mdck
cell
infect
procedur
cell
conduct
describ
earlier
hrinciu
et
al
human
rsv
alter
glycosyl
studi
grown
either
vero
cell
cell
alter
surfac
protein
describ
earlier
kwila
et
al
chemic
chaperon
pba
sigmaaldrich
sodium
salt
tudca
sigmaaldrich
sodium
salt
chemic
inhibitor
imatinib
mesyl
selleckchem
bacteri
cell
wall
polym
lta
invivogen
dissolv
water
use
indic
analysi
number
infecti
particl
plaqu
titer
conduct
collect
sampl
tissu
cultur
supernat
lung
homogen
indic
point
time
postinfect
pi
assess
standard
plaqu
titrat
describ
earlier
hrinciu
et
al
mous
studi
perform
complianc
anim
welfar
regul
anim
protocol
approv
anim
care
use
committe
st
jude
children
research
hospit
seven
eightweekold
femal
balbc
mice
wt
j
mice
jackson
laboratori
use
mous
studi
anim
lightli
anesthet
inhal
isofluran
baxter
afterward
infect
intranas
indic
virus
plaqueform
unit
pfu
final
volum
mice
monitor
daili
weight
loss
diseas
symptom
mortal
accord
protect
anim
welfar
restrict
mice
sacrif
weight
loss
consid
die
specif
day
determin
viru
titer
cytokinechemokin
protein
level
mous
lung
collect
pb
homogen
use
homogen
lyse
matrix
mp
biomed
adjust
pb
obtain
tissu
homogen
sampl
clear
debri
supernat
use
viru
titer
determin
standard
plaqu
titrat
measur
concentr
interleukin
tumor
necrosi
factor
tnf
chemokin
cc
motif
ligand
use
custom
multiplex
cytokinechemokin
assay
millipor
analyz
luminex
xpotent
system
biorad
follow
manufactur
protocol
total
rna
cell
isol
use
rneasi
mini
kit
qiagen
accord
manufactur
protocol
analysi
cytokinechemokin
level
mous
lung
collect
trizol
rna
isol
use
trizol
method
chomczynski
sacchi
purelink
rna
mini
kit
ambion
revers
transcript
mrna
total
rna
oligo
dt
primer
use
revers
transcript
done
use
mmlv
revers
transcriptas
promega
accord
manufactur
protocol
qpcr
reaction
quantitect
sybr
green
pcr
kit
qiagen
use
accord
manufactur
recommend
rel
mrna
concentr
determin
cycl
amplif
appli
biosystem
reatim
pcr
system
use
method
livak
schmittgen
housekeep
gene
gapdh
serv
intern
standard
follow
primer
use
quantitect
primer
qiagen
primer
human
fwd
rev
human
fwd
rev
human
fwd
rev
human
total
fwd
rev
human
splice
fwd
rev
er
stress
gene
primer
sequenc
taken
oslowski
urano
quantif
influenza
mrna
fwd
cttctaaccgaggtcgaaacgta
rev
ggattggtcttgtctttagcca
di
trani
et
al
primer
use
quantif
rsv
gene
realtim
rtpcr
perform
previous
publish
boukhvalova
et
al
total
rna
revers
transcrib
cdna
antigenom
primer
oligo
dt
primer
housekeep
gene
use
superscript
iii
firststrand
synthesi
system
life
technolog
realtim
pcr
perform
primer
use
power
sybr
green
pcr
master
mix
life
technolog
lightcycl
ii
roch
rel
amount
rsv
normal
primer
use
method
quantit
realtim
pcrbase
cytokinechemokin
analysi
profil
pcr
array
human
signal
target
qiagen
conduct
accord
manufactur
protocol
data
analysi
conduct
profil
pcr
array
data
analysi
softwar
qiagen
webpag
western
blot
analysi
conduct
describ
earlier
hrinciu
et
al
brief
cell
lyse
clear
debri
bradford
method
use
protein
concentr
measur
final
cell
lysat
use
protein
express
analysi
use
western
blot
techniqu
activ
er
stress
analyz
phosphoryl
rabbit
polyclon
antibodi
pab
novu
biolog
perk
antiperk
rabbit
monoclon
antibodi
mab
cell
signal
technolog
cleavag
mous
mab
novu
biolog
analysi
mapk
activ
conduct
analysi
jnk
phosphoryl
antijnk
rabbit
mab
cell
signal
technolog
phosphoryl
rabbit
mab
cell
signal
technolog
express
influenza
protein
detect
use
specif
mous
mab
abcam
specif
mous
mab
develop
imv
detect
rabbit
mab
cell
signal
technolog
rabbit
mab
cell
signal
technolog
perk
antiperk
mous
pab
rockland
tubulin
rabbit
mab
cell
signal
technolog
use
control
protein
band
final
visual
use
standard
enhanc
chemiluminesc
ecl
reaction
microarray
analysi
gene
express
mous
lung
total
lung
rna
isol
describ
rna
qualiti
confirm
analysi
agili
bioanalyz
total
rna
ng
process
hartwel
center
microarray
core
accord
affymetrix
genechip
whole
transcript
label
protocol
biotinyl
cdna
fragment
hybrid
affymetrix
genechip
mous
gene
st
array
stain
scan
accord
manufactur
instruct
data
rma
summar
irizarri
et
al
visual
pca
next
probe
set
statist
test
use
anova
result
p
valu
adjust
multipl
test
bonferroni
storey
q
valu
method
storey
tibshirani
use
partek
genom
suit
hierarch
cluster
heatmap
visual
z
score
normal
data
complet
data
select
gene
perform
use
spotfir
decis
site
gene
ontolog
go
enrich
analysi
perform
david
bioinformat
resourc
softwar
develop
provid
nation
institut
allergi
infecti
diseas
niaid
huang
et
al
go
bar
chart
score
visual
statamp
analysi
infiltr
inflammatori
cell
mous
lung
marker
lung
injuri
balf
collect
indic
point
time
describ
earlier
hrinciu
et
al
harvest
balf
cell
purifi
count
fac
analyz
describ
previous
hrinciu
et
al
brief
fac
analys
conduct
obtain
count
resid
macrophag
low
high
mhcii
low
exud
macrophag
high
int
mhcii
low
neutrophil
remain
cellfre
balf
use
investig
marker
lung
injuri
total
protein
concentr
measur
via
bradford
assay
biorad
ldh
measur
via
ldh
assay
sigmaaldrich
execut
accord
manufactur
protocol
detail
patholog
investig
mice
lung
anim
euthan
lung
fix
via
intratrach
infus
follow
immers
neutral
buffer
formalin
solut
afterward
tissu
sampl
embed
paraffin
automat
section
final
stain
h
e
review
conduct
veterinari
pathologist
blind
purpos
studi
group
composit
obtain
gross
patholog
evalu
patholog
score
lung
edema
investig
total
lung
collect
wet
lung
weight
determin
marker
inflamm
patholog
lung
afterward
lung
dri
hr
weigh
obtain
dri
lung
weight
final
wetdri
lung
weight
ratio
calcul
marker
lung
edema
analysi
lung
physiolog
upon
influenza
viru
infect
anim
anesthet
mgml
xylazin
vedco
mgml
euthasol
virbac
prior
surgic
intub
attach
flexiv
small
anim
ventil
scireq
use
mous
inhal
dose
respons
script
baselin
respons
mgml
sigmaaldrich
gather
softwaregener
valu
respiratori
system
resist
rr
complianc
cr
elast
er
newtonian
resist
rn
tissu
damp
g
tissu
elast
h
record
mean
calcul
anim
prior
obtain
mean
sd
mean
group
comparison
surviv
curv
group
mice
period
day
conduct
use
log
rank
chisquar
test
statist
analysi
kaplanmei
surviv
data
anova
tukey
test
multipl
comparison
use
multipl
comparison
data
cytokinechemokin
level
singleday
weight
loss
vivo
viral
titer
cell
count
lung
patholog
marker
patholog
score
lung
physiolog
data
etc
student
test
welch
correct
sampl
unequ
varianc
use
comparison
viral
titer
viral
rna
vitro
student
test
analysi
correct
multipl
test
holmsidak
method
twoway
anova
repeat
measur
tukey
test
multipl
comparison
conduct
weight
loss
data
period
day
p
valu
consid
signific
comparison
graphpad
softwar
use
statist
analys
erh
sl
jam
design
project
experi
analyz
data
set
manuscript
experi
conduct
erh
support
sg
df
microarray
data
pv
lung
patholog
ae
lung
physiolog
dy
sac
rsv
rsv
vero
involv
experiment
procedur
andor
data
analysi
